Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications.

Amin MA, Zehravi M, Sweilam SH, Darwin R, Gupta JK, Bhargav E, Dharmamoorthy G, Kumar VV, Rao AA, Suliman M, Periyasamy T, Emran TB.

Open source

DOI
10.2174/0118715273427644251204045253
Published
2026-05-22
Container
CNS Neurol Disord Drug Targets
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0118715273427644251204045253,
  title = {Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications.},
  author = {Amin MA and  Zehravi M and  Sweilam SH and  Darwin R and  Gupta JK and  Bhargav E and  Dharmamoorthy G and  Kumar VV and  Rao AA and  Suliman M and  Periyasamy T and  Emran TB.},
  year = {2026},
  journal = {CNS Neurol Disord Drug Targets},
  doi = {10.2174/0118715273427644251204045253},
  url = {https://doi.org/10.2174/0118715273427644251204045253}
}

RIS

TY  - JOUR
TI  - Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications.
AU  - Amin MA
AU  -  Zehravi M
AU  -  Sweilam SH
AU  -  Darwin R
AU  -  Gupta JK
AU  -  Bhargav E
AU  -  Dharmamoorthy G
AU  -  Kumar VV
AU  -  Rao AA
AU  -  Suliman M
AU  -  Periyasamy T
AU  -  Emran TB.
PY  - 2026
JO  - CNS Neurol Disord Drug Targets
DO  - 10.2174/0118715273427644251204045253
UR  - https://doi.org/10.2174/0118715273427644251204045253
ER  - 

APA

MA, A., M, Z., SH, S., R, D., JK, G., E, B., G, D., VV, K., AA, R., M, S., T, P., & TB., E. (2026). Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications.. CNS Neurol Disord Drug Targets. https://doi.org/10.2174/0118715273427644251204045253

Source records